Advances in norovirus biology

Stephanie M. Karst, Christiane E. Wobus, Ian G. Goodfellow, Kim Y. Green, Herbert W. Virgin

Research output: Contribution to journalReview articlepeer-review

160 Scopus citations


Human noroviruses are a major cause of epidemic and sporadic gastroenteritis worldwide and can chronically infect immunocompromised patients. Efforts to develop effective vaccines and antivirals have been hindered by the uncultivable nature and extreme genetic diversity of human noroviruses. Although they remain a particularly challenging pathogen to study, recent advances in norovirus animal models and in vitro cultivation systems have led to an increased understanding of norovirus molecular biology and replication, pathogenesis, cell tropism, and innate and adaptive immunity. Furthermore, clinical trials of vaccines consisting of nonreplicating virus-like particles have shown promise. In this review, we summarize these recent advances and discuss controversies in the field, which is rapidly progressing toward generation of antiviral agents and increasingly effective vaccines.

Original languageEnglish
Pages (from-to)668-680
Number of pages13
JournalCell Host and Microbe
Issue number6
StatePublished - Jun 11 2014


Dive into the research topics of 'Advances in norovirus biology'. Together they form a unique fingerprint.

Cite this